retatrutide semaglutide vs can you switch from retatrutide

#GLP1 #Noom #ObesityTreatment #DigitalHealth #WeightLoss #Semaglutide #HealthTech #CompoundedDrugs #PharmaInnovation #BehavioralHealth Noom launches Microdose GLP-1Rx Program for affordable weight loss Noom has launched its Microdose GLP-1Rx Program to improve affordability and reduce side effects tied to weight loss medications

Thyroid disorders, including Hashimotos thyroiditis and hypothyroidism, are common in people with metabolic diseases like diabetes and obesity

Perceptions around the high costs of these medications, even with insurance approval, have created barriers for many, especially low-income individuals

It works by mimicking a hormone that tells your brain you're full

This biomarker context should be interpreted by a qualified healthcare provider and combined with clinical assessment, not used as a standalone predictor of medication efficacy or insurance eligibility